Holding(s) in Company
August 08 2007 - 9:53AM
UK Regulatory
RNS Number:7570B
Healthcare Enterprise Group PLC
08 August 2007
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
Healthcare Enterprise Group Plc
2. Reason for the notification (please place an X inside the appropriate
bracket/s):
An acquisition or disposal of voting rights: ( x )
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
.................
3. Full name of person(s) subject to the notification obligation (iii):
Hargreave Hale Limited
4. Full name of shareholder(s) (if different from 3.) (iv):
5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):
07 August 2007
6. Date on which issuer notified:
08 August 2007
7. Threshold(s) that is/are crossed or reached:
5%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible Situation previous to the Triggering transaction (vi)
using the ISIN CODE
Number of shares Number of voting Rights (viii)
Ordinary
GB00B047X073 16,163,000 16,163,000
Resulting situation after the triggering transaction (vii)
Class/type of shares if Number of shares Number of voting rights % of voting rights
possible using the ISIN (ix)
CODE
Direct Indirect Direct (x) Indirect Direct Indirect
(xi)
- 15,163,000 - 15,163,000 - 4.9874%
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/Conversion Number of voting rights % of voting rights
financial (xiii) Period/ Date (xiv) that may be acquired if the
instrument instrument is exercised/
converted.
Total (A+B)
Number of voting rights % of voting rights
15,163,000 4.9874%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
15,160,000 of these shares are for a unit trust operated by Marlborough Fund
Managers Ltd, for which Hargreave Hale manages the investments on a
discretionary basis. The remaining balance is held on behalf of other
discretionary clients.
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
The "situation previous" percentage has been calculated using the denominator of
304,028,656 shares in issue and voting rights, as stated in the company's
announcement on 2nd May 2007.
14. Contact name:
David Clueit
15. Contact telephone number:
01253 754 739
Annex to Notification Of Major Interests In Shares (xvi)
A: Identity of the person or legal entity subject to the notification obligation
Full name (including legal form for legal entities):
Hargreave Hale Limited
Contact address (registered office for legal entities):
Marsden House
4-10 Springfield Road
Blackpool FY1 1QW
Phone number:
01253 754 739
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWVSRBURWRAR
Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Healthcare Enterprise (LSE:HCEG)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Healthcare Ent. (London Stock Exchange): 0 recent articles
More Healthcare Ent. Grp. News Articles